Nippon Shinyaku Co., Ltd. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2021
August 10, 2021 at 02:00 am EDT
Share
Nippon Shinyaku Co., Ltd. announced consolidated earnings results for the first quarter ended June 30, 2021. For the quarter, the company reported net sales were JPY41,157 million, an increase of 37.6% year on year. Operating profit was JPY16,448 million, an increase of 118.6% year on year. Net income was JPY12,341 million, an increase of 111.5% year on year.
Nippon Shinyaku Co., Ltd. is a Japan-based company principally involved in the manufacture and sale of pharmaceutical products and functional foodstuffs. The Company operates in two business segments. The Pharmaceutical segment is involved in the manufacture and sale of urinary system therapeutic agents, blood cancer therapeutic agents, pain, inflammation and allergic therapeutic agents, digestive system therapeutic agents, cardiovascular systems and metabolic therapeutic agents. The Functional Foodstuff segment involves in the manufacture and sale of health food materials, quality stability preservatives, protein preparation, spice and seasoning products. The Company is also involved in the business support business, non-life insurance agency business, as well as the provision of real estate leasing services.
NIPPON SHINYAKU CO., LTD. 
